AKT1 and COVID-19: Although no evidence has shown relevance between PI3K/Akt pathway and NRF2 in COVID-19, PI3K/Akt is probably associated with the inactivated NRF2, as such mechanism has been verified in chronic obstructive pulmonary disease (51).